(Q42451765)

31 October 2017

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates (English)

1 reference

31 October 2017

Athanasios Dimopoulos

6

1 reference

31 October 2017

Nakopoulou L

1

1 reference

31 October 2017

Vourlakou C

2

1 reference

31 October 2017

Zervas A

3

1 reference

31 October 2017

Tzonou A

4

1 reference

31 October 2017

Gakiopoulou H

5

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

31 October 2017

1 reference

31 October 2017

29

1 reference

31 October 2017

146-154

1 reference

31 October 2017

2

1 reference

Apoptosis. Its significance in cancer and cancer therapy

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Bcl-2 and the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Programmed cell death: apoptosis and oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Involvement of the bcl-2 gene in human follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Apoptosis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

p53 expression and prognosis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

P53 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990225-8

7 January 2021

10.1016/S0046-8177(98)90225-8

Identifiers

DOI

1 reference

31 October 2017

1 reference